Oliver Schnell
University of Bern(CH)University of Freiburg(DE)German Cancer Research Center(DE)Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Heidelberg University(DE)University Hospital of Bern(CH)University Medical Center Freiburg(DE)Universitätsklinikum Erlangen(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, Meningioma and schwannoma management, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial(2014)1,009 cited
- → Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma(2022)589 cited
- → Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial(2019)568 cited
- → Mapping microglia states in the human brain through the integration of high-dimensional techniques(2019)451 cited
- → A vaccine targeting mutant IDH1 in newly diagnosed glioma(2021)411 cited
- → Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma